Pfizer to pay $2.26B for cancer treatment developer Trillium
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay
Read more
World-first study uses artificial intelligence to map the risks of ovarian cancer in women
The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most
Read more
Predicting whether bowel cancers will respond to immunotherapy
Scientists from the Francis Crick Institute and King’s College London have studied colorectal cancer and found that levels of specific
Read more